Nolan Garry Ph.D. 4
4 · Akoya Biosciences, Inc. · Filed May 25, 2021
Insider Transaction Report
Form 4
Nolan Garry Ph.D.
Director
Transactions
- Award
Stock Option (Right to Buy
2021-05-21+16,860→ 16,860 totalExercise: $21.95Exp: 2031-05-21→ Common Stock (16,860 underlying)
Holdings
- 680,084
Common Stock
Footnotes (1)
- [F1]Subject to the reporting person's continuous service through the vesting date, the options shall vest in full on the earlier of (a) May 21, 2022, or (b) the date of the next annual meeting of Akoya Biosciences, Inc. occurring after the date of grant.